Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Short term Debt (2016 - 2025)

Nutex Health's Short term Debt history spans 11 years, with the latest figure at $740000.0 for Q4 2025.

  • For Q4 2025, Short term Debt fell 94.86% year-over-year to $740000.0; the TTM value through Dec 2025 reached $740000.0, down 94.86%, while the annual FY2025 figure was $740000.0, 94.86% down from the prior year.
  • Short term Debt for Q4 2025 was $740000.0 at Nutex Health, down from $5.3 million in the prior quarter.
  • Across five years, Short term Debt topped out at $19.6 million in Q3 2023 and bottomed at $72055.0 in Q4 2021.
  • The 5-year median for Short term Debt is $4.5 million (2022), against an average of $7.5 million.
  • The largest annual shift saw Short term Debt surged 3540.94% in 2022 before it plummeted 94.86% in 2025.
  • A 5-year view of Short term Debt shows it stood at $72055.0 in 2021, then soared by 3540.94% to $2.6 million in 2022, then grew by 28.52% to $3.4 million in 2023, then soared by 326.94% to $14.4 million in 2024, then tumbled by 94.86% to $740000.0 in 2025.
  • Per Business Quant, the three most recent readings for NUTX's Short term Debt are $740000.0 (Q4 2025), $5.3 million (Q3 2025), and $19.0 million (Q2 2025).